COPD could be a problem with autoimmunity
2010-11-20
(Press-News.org) Moderate to severe chronic obstructive pulmonary disease (COPD) may be an auto-immunity problem, according to researchers in Spain, who studied the presence of auto-antibodies in patients with COPD and compared them to levels of control subjects. They found that a significant number of patients with COPD had significant levels of auto-antibodies circulating in their blood, about 5 to 10 times the level in controls.
The findings were published online ahead of the print edition of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
"We showed that between one third and one quarter of patients with clinically stable COPD present abnormal levels of circulating auto-antibodies in the blood," said Jaume Sauleda M.D., coordinator of respiratory medicine department, Hospital Universitari Son Dureta, Palma Mallorca, Spain. "Our findings provide further support for the hypothesis that the pathogenesis of COPD involves an auto-immune component."
The researchers recruited 328 patients with clinically stable COPD three months after hospitalization for the first time with an exacerbation of the disease at nine participating hospitals in Spain, and 67 healthy volunteers from primary care clinics, blood donors and hospital workers. They collected information on current and past smoking habits, comorbidities, and data such as body mass index, degree of dyspnea and six-minute walk distance. They tested lung function with spirometry.
They then took blood samples and tested the blood for antinuclear antibodies (ANA), anti-tissue antibodies (AT) including mitochondrial (AMA), liver-kidney microsomal (LKM), smoothmuscle (SMA), and parietal gastric cell (PGC) antibodies. The serum levels of C-reactive protein were also tested in patients.
"We wanted to quantify the levels of auto-antibodies in COPD with respect to the patients' lung function and disease severity. By doing so, we hoped to determine whether in fact COPD had an auto-immune aspect," said Dr. Sauleda. "COPD is the fourth-leading cause of death in the world, and is becoming increasingly common in the developing world as generations of heavy smokers age. Understanding its pathogenesis is key to developing effective treatments that go beyond symptom palliation."
The researchers found that, overall, 34 percent of COPD patients had abnormally high levels of ANA titer—a prevalence 11 times higher than seen in the control group, and 7 times higher than reported in healthy subjects in previous studies. Furthermore, 26 percent of the patients were positive for AT, a prevalence 4.5 times higher than in the controls, and 4 times higher than reported in healthy subjects in other studies.
Patients with AT tended to be younger and active smokers, and the level of these auto-antibodies was related to impairment of lung function. There were no other associations between auto-antibodies and other patient characteristics.
The much higher prevalence of auto-antibodies in COPD patients has several implications and possible explanations. Other studies have found that patients with "severe bronchitis" (which would probably be characterized as COPD today) had high levels of circulating ANA, and these results confirm those earlier findings. Recent reports have also suggested that circulating antibodies are directed against components of the lung matrix and epithelium in patients with COPD.
"We can only speculate on the mechanisms underlying the observed associations," said Dr. Sauleda. "The prevalence of ANA and AT may be non-specific markers of an ongoing auto-immune response or may be directly involved in the pathogenesis of the disease. However, these alternatives are not mutually exclusive. "Future longitudinal studies in general population evaluating the relationships between these auto-antibodies and lung function during several years can help us to unravel this issue."
Dr. Sauleda continued, "If future research confirms the suspected auto-immune component of COPD, it raises the possibility of future clinical trials evaluating possible new therapies for this disease, for instance, immunomodulators."
### END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-20
TORONTO, Nov. 19, 2010--For every one person in Canada who is homeless, another 23 live in unsafe, crowded or unaffordable housing, meaning the country's housing crisis is even worse than previously thought, according to Dr. Stephen Hwang of St. Michael's Hospital in Toronto.
Those "vulnerably housed" people have the same severe health problems and dangers of assault as homeless people, said Hwang, principal investigator of a new report on housing and health issues in Vancouver, Toronto and Ottawa.
"The key point is that Canada needs a national housing strategy," ...
2010-11-20
Eating five portions of fruit and vegetables per day is one of the means that experts most frequently recommend for preventing cancer. Now, the European EPIC study carried out by researchers from 10 countries has shown that, in the case of lung cancer, the important thing is not just the quantity but also the variety of fruit consumed, which can reduce the risk by up to 23%.
"This research looks more deeply into the relationship between diet and lung cancer", María José Sánchez Pérez, co-author of the study and director of the Granada Cancer Registry at the Andalusian ...
2010-11-20
Researchers from Institute of Environmental Science and Technology (ICTA), at Universitat Autònoma de Barcelona (UAB), and other universities have published a special section in the journal Ecological Economics that analyzes the link between ecological economics and political ecology. This issue stems from the institute's research on impacts and resistance at the "commodity frontiers", where the extraction of natural resources and the disposal of toxic wastes produce a range of economic, environmental, cultural and social conflicts.
The special issue, titled Social Metabolism, ...
2010-11-20
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Social scientists Professor Zoë Matthews and Dr Sarah Neal are working in collaboration with the White Ribbon Alliance for Safe Motherhood and the University of Aberdeen on a joint project worth in excess of £160,000 called 'The Atlas of Birth', which also includes a book, short film and flyers.
"We are using data from the United Nations ...
2010-11-20
For the first time, there is no need to chemically fix, stain or cut cells in order to study them. Instead, whole living cells are fast-frozen and studied in their natural environment. The new method delivers an immediate 3-D image, thereby closing a gap between conventional microscopic techniques.
The new microscope delivers a high-resolution 3-D image of the entire cell in one step. This is an advantage over electron microscopy, in which a 3-D image is assembled out of many thin sections. This can take up to weeks for just one cell. Also, the cell need not be labelled ...
2010-11-20
Scientists at The Children's Hospital of Philadelphia have identified both common and rare gene variants associated with the eating disorder anorexia nervosa. In the largest genetic study of this psychiatric disorder, the researchers found intriguing clues to genes they are subjecting to further investigation, including genes active in neuronal signaling and in shaping interconnections among brain cells.
Anorexia nervosa (AN) affects an estimated 9 in 1000 women in the United States. Patients have food refusal, weight loss, an irrational fear of weight gain even when ...
2010-11-20
Boston, Mass. – Although people infected with HIV produce many antibodies against the protein encapsulating the virus, most of these antibodies are strangely ineffective at fighting the disease. A new study suggests why some of the most common of these antibodies don't work: they target the protein in a form it takes after the virus has already invaded the cell, when it's too late, report researchers at Children's Hospital Boston and their colleagues.
The findings, published online Nov. 14 in the journal Nature Structural & Molecular Biology, refocus attention on the ...
2010-11-20
MONTREAL, CANADA - November 19, 2010 - Data presented today from a pivotal, phase III randomized clinical trial for patients with recurrent glioblastoma tumors suggest that Tumor Treating Fields (TTF) therapy may increase median survival time and improve quality of life scores compared to best standard of care chemotherapy. Professor Zvi Ram, chairman of the Department of Neurosurgery at Tel-Aviv Sourasky Medical Center, presented the data at the Society for Neuro-Oncology (SNO) Annual Scientific Meeting.
Physicians delivered the investigational TTF therapy to patients ...
2010-11-20
New Rochelle, NY, November 19, 2010—Mounting evidence linking childhood obesity to an increasing risk of obesity, heart disease, type 2 diabetes, and other cardiovascular and metabolic disorders in adulthood is clearly presented in a comprehensive review article in the current issue of Childhood Obesity, published by Mary Ann Liebert, Inc. The article is available free online.
Authors Megan Moriarty-Kelsey, MD and Stephen Daniels, MD, PhD, Department of Pediatrics, University of Colorado School of Medicine, caution that the rising prevalence of obesity in children will ...
2010-11-20
An old pinworm medicine is a new lead in the search for compounds that block a signaling pathway implicated in colon cancer. The findings, reported by Vanderbilt University Medical Center researchers in the November issue of Nature Chemical Biology, suggest a fresh approach for developing therapeutics that target the pathway.
More than 90 percent of sporadic (non-inherited) colon cancers – the second deadliest type of cancer in the developed world – are caused by mutations that result in inappropriate activation of the Wnt (pronounced "wint") signaling pathway. Blocking ...
LAST 30 PRESS RELEASES:
[Press-News.org] COPD could be a problem with autoimmunity
